Volume 2 Issue 5: December 2013

1 A Chronopharmacological Study Related to Doxorubicin Based BoneMarrow Suppression Dr. Vijayalakshmi Subbiah, Dr. Rajendran K., Dr. Shanthi M., Dr. Parameswari R. Abstract: Myelosuppression is the most common toxicity of anti-neoplastic therapy due to inhibition of cell replication in bone marrow. This can be minimized by administering drugs on the basis of circadian time basis. Read more about Volume 2 Issue 5: December 2013[…]